Phase 2 MASLD - Metabolic Dysfunction-Associated Steatotic Liver Disease trials recruiting now

All MASLD - Metabolic Dysfunction-Associated Steatotic Liver Disease trials, every phase

Phase 2 MASLD - Metabolic Dysfunction-Associated Steatotic Liver Disease trials

• A Study to Evaluate the Use of Resmetirom in Participants With MASLD and HIV
  NCT07143968 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 10 locations
• Effect of Ketone Esters on Liver Fat Content and Metabolic Function
  NCT07097506 · Phase: Phase 2 · Ages: 18 Years to 40 Years · Sex: All (male and female) · 1 location
• Investigation of the Efficacy of a Probiotic Mixture in Moderate Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): A Mechanistic Trial
  NCT07193927 · Phase: Phase 2 · Ages: 18 Years to 75 Years · Sex: All (male and female) · 1 location

Common questions

What does Phase 2 mean?

See how clinical trials work.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.